These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38001876)

  • 21. Tissue-resident CXCR4
    Liao Z; Ye L; Li T; Jin X; Lin X; Fei Q; Zhang H; Shi S; Yu X; Jin K; Wu W
    Int J Cancer; 2023 Jun; 152(11):2396-2409. PubMed ID: 36757203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer.
    Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E
    Front Immunol; 2021; 12():643529. PubMed ID: 33679807
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy.
    Xi J; Huang Q; Wang L; Ma X; Deng Q; Kumar M; Zhou Z; Li L; Zeng Z; Young KH; Zhang M; Li Y
    Oncogene; 2018 Jun; 37(23):3151-3165. PubMed ID: 29540832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
    Kabacaoglu D; Ciecielski KJ; Ruess DA; Algül H
    Front Immunol; 2018; 9():1878. PubMed ID: 30158932
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Zhang W; Xu L; Zhang X; Xu J; Jin JO
    Front Immunol; 2023; 14():1213467. PubMed ID: 37720226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer.
    Li TJ; Jin KZ; Li H; Ye LY; Li PC; Jiang B; Lin X; Liao ZY; Zhang HR; Shi SM; Lin MX; Fei QL; Xiao ZW; Xu HX; Liu L; Yu XJ; Wu WD
    Cancer Lett; 2022 Apr; 530():142-155. PubMed ID: 35077803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
    Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal Adenocarcinoma.
    Coleman MF; Liu KA; Pfeil AJ; Etigunta SK; Tang X; Fabela S; Lashinger LM; Cui Z; Hursting SD
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer.
    Sun L; Zhang Y; Yang T; Chen J; Zhang X; Liang X
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.
    Kuo CL; Chou HY; Lien HW; Yeh CA; Wang JR; Chen CH; Fan CC; Hsu CP; Kao TY; Ko TM; Lee AY
    Cancer Immunol Immunother; 2023 Feb; 72(2):351-369. PubMed ID: 35895109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA LINC01569 promotes M2 macrophage polarization to accelerate hypopharyngeal carcinoma progression through the miR-193a-5p/FADS1 signaling axis.
    Gong Q; Li H; Song J; Lin C
    J Cancer; 2023; 14(9):1673-1688. PubMed ID: 37325064
    [No Abstract]   [Full Text] [Related]  

  • 35. Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU).
    Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M
    Front Immunol; 2022; 13():1060957. PubMed ID: 36591282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment.
    Garcia Garcia CJ; Huang Y; Fuentes NR; Turner MC; Monberg ME; Lin D; Nguyen ND; Fujimoto TN; Zhao J; Lee JJ; Bernard V; Yu M; Delahoussaye AM; Jimenez Sacarello I; Caggiano EG; Phan JL; Deorukhkar A; Molkentine JM; Saur D; Maitra A; Taniguchi CM
    Gastroenterology; 2022 Jun; 162(7):2018-2031. PubMed ID: 35216965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking Macrophage Infiltration in a Mouse Model of Pancreatic Cancer with the Positron Emission Tomography Tracer [11C]PBR28.
    Lanfranca MP; Lazarus J; Shao X; Nathan H; Di Magliano MP; Zou W; Piert M; Frankel TL
    J Surg Res; 2018 Dec; 232():570-577. PubMed ID: 30463776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer.
    Xi Q; Chen Y; Yang GZ; Zhang JY; Zhang LJ; Guo XD; Zhao JY; Xue ZY; Li Y; Zhang R
    Front Immunol; 2020; 11():890. PubMed ID: 32536914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview.
    Panchal K; Sahoo RK; Gupta U; Chaurasiya A
    Int Immunopharmacol; 2021 Jun; 95():107508. PubMed ID: 33725635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma.
    Gu H; Deng W; Zhang Y; Chang Y; Shelat VG; Tsuchida K; Lino-Silva LS; Wang Z
    Transl Lung Cancer Res; 2022 May; 11(5):858-868. PubMed ID: 35693281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.